ArticleJB & JS open access
Association Between Peripheral Nerve Blocks and Cardiovascular Outcomes in Older Adults with Hip Fractures: An Analysis of the Premier Healthcare Database.
Article in JB & JS open access. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Background: Hip fractures in older adults carry substantial perioperative risk, with cardiovascular complications being a major concern. The dual physiologic stress from fracture and surgical repair activates neuroendocrine pathways and creates sympathovagal imbalance. While peripheral nerve blocks are established for analgesia in hip fracture management, their potential to attenuate the surgical stress response and reduce cardiovascular complications remains unclear. This study evaluated the association between peripheral nerve blocks and cardiac events in older adults undergoing hip fracture surgery. Methods: This cohort study used the Premier Healthcare Database, including patients aged 65 years or older with hip fractures surgically treated in 2022 or 2023. Peripheral nerve block administration was identified through procedure codes and pharmacy records. Propensity score matching (1:1) balanced baseline characteristics between groups. The primary outcome was myocardial infarction during index hospitalization. Secondary outcomes included other cardiac events and noncardiac complications. All-cause 90-day readmission was an exploratory outcome. Results: Among 23,812 eligible patients, 3,299 (14%) received peripheral nerve blocks. After propensity matching, each group contained 3,299 patients (median age 81 years). Myocardial infarction showed a protective point estimate but did not reach statistical significance (risk ratio [RR] 0.64; 95% confidence interval [CI]:0.37-1.12; p = 0.12). Nerve blocks were associated with reduced acute congestive heart failure (RR 0.47; 95% CI: 0.31-0.72; p < 0.001) and cardiac arrest (RR 0.41; 95% CI: 0.19-0.90; p = 0.03). Nerve blocks were also associated with a reduced risk of 90-day hospital readmission (RR 0.82; 95% CI: 0.72-0.93; p = 0.003). Conclusions: Peripheral nerve blocks were associated with reduced cardiovascular complications in older adults undergoing hip fracture surgery. While myocardial infarction rates were similar between groups, nerve blocks were associated with reduced in-hospital acute congestive heart failure and cardiac arrest. These findings are hypothesis-generating for cardioprotective effects from peripheral nerve blocks. Level of Evidence: Level III, Therapeutic. See Instructions for Authors for a complete description of levels of evidence.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.